Early detection with IMMray™ PanCan-d

By early diagnosis – or early detection – of pancreatic cancer, we mean the detection of the cancer in stage I or stage II, when the cancer is still resectable by surgical procedure. Because of the nature and aggressivity of the disease, early diagnosis is by far the best hope for treatment and long-term control of pancreatic cancer.

There is currently no standard diagnostic tool or method for the early detection of pancreatic cancer. A test that is sensitive and specific enough to detect pancreatic cancer in its earliest stages has the potential of saving many lives.

Read more from the IMMray™ PanCan-d poster presentation at the PancreasFest 2019, Pittsburgh (PA), USA, July 24-26, 2019.

Link to IMMray™ PanCan-d results published in Journal of Clinical Oncology. Flyer for download (Pdf).


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports